Literature DB >> 18482083

Protease-activated receptor 2 and gut permeability: a review.

L Bueno1, J Fioramonti.   

Abstract

Digestive tract proteases are best known for their proteolytic activity in the digestion of alimentary proteins. However, during the last decade, a possible role of proteases as signalling molecules has been emphasized with the discovery of a novel class of G-protein coupled receptors located on cell membranes that may be activated by proteolytic cleavage of their N-terminal extracellular domain. Type 2 protease-activated receptors (PAR-2) are cleaved by serine-proteases such as trypsin and tryptase. PAR-2 is present in many intestinal cell types and particularly on epithelial cells. Multiple functions have been demonstrated in the gut for PAR-2, including epithelial permeability, mainly the intercellular permeability that is of paramount importance in the equilibrium between the external milieu (digestive contents) and the submucosal immune system. Alterations of both tissue and luminal levels of proteases or serine-protease activity may affect gut permeability and subsequently the immune status of the mucosa. Activation of PAR-2 on epithelial cells may directly affect cytoskeleton contraction by triggering phosphorylation of myosin light chain with subsequent changes in tight junction permeability. Enhanced fecal protease level has been recently reported in both organic (ulcerative colitis) and functional (irritable bowel syndrome) intestinal disorders and may play a role in the pathogenesis of such diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18482083     DOI: 10.1111/j.1365-2982.2008.01139.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  24 in total

1.  Gastrointestinal absorption and biological activities of serine and cysteine proteases of animal and plant origin: review on absorption of serine and cysteine proteases.

Authors:  Gerhard Lorkowski
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-02-28

2.  Activation of protease activated receptor 2 by exogenous agonist exacerbates early radiation injury in rat intestine.

Authors:  Junru Wang; Marjan Boerma; Ashwini Kulkarni; Morley D Hollenberg; Martin Hauer-Jensen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-15       Impact factor: 7.038

3.  Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury: potential role in pulmonary fibrosis.

Authors:  Keren Borensztajn; Paul Bresser; Chris van der Loos; Ilze Bot; Bernt van den Blink; Michael A den Bakker; Joost Daalhuisen; Angelique P Groot; Maikel P Peppelenbosch; Jan H von der Thüsen; C Arnold Spek
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

4.  Role of enteric nerves in immune-mediated changes in protease-activated receptor 2 effects on gut function.

Authors:  T Shea-Donohue; L Notari; J Stiltz; R Sun; K B Madden; J F Urban; A Zhao
Journal:  Neurogastroenterol Motil       Date:  2010-07-11       Impact factor: 3.598

5.  The Altered Mucosal Barrier Function in the Duodenum Plays a Role in the Pathogenesis of Functional Dyspepsia.

Authors:  Keishi Komori; Eikichi Ihara; Yosuke Minoda; Haruei Ogino; Taisuke Sasaki; Minako Fujiwara; Yoshinao Oda; Yoshihiro Ogawa
Journal:  Dig Dis Sci       Date:  2019-01-23       Impact factor: 3.199

6.  Changes in Epithelial Barrier Function in Response to Parasitic Infection: Implications for IBD Pathogenesis.

Authors:  Joan Antoni Fernández-Blanco; Javier Estévez; Terez Shea-Donohue; Vicente Martínez; Patri Vergara
Journal:  J Crohns Colitis       Date:  2015-03-28       Impact factor: 9.071

Review 7.  The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease.

Authors:  Tim Vanuytsel; Séverine Vermeire; Isabelle Cleynen
Journal:  Tissue Barriers       Date:  2013-12-10

8.  Serotonin disrupts esophageal mucosal integrity: an investigation using a stratified squamous epithelial model.

Authors:  Liping Wu; Tadayuki Oshima; Toshihiko Tomita; Yoshio Ohda; Hirokazu Fukui; Jiro Watari; Hiroto Miwa
Journal:  J Gastroenterol       Date:  2016-03-16       Impact factor: 7.527

9.  The active Zot domain (aa 288-293) increases ZO-1 and myosin 1C serine/threonine phosphorylation, alters interaction between ZO-1 and its binding partners, and induces tight junction disassembly through proteinase activated receptor 2 activation.

Authors:  Simeon E Goldblum; Usha Rai; Amit Tripathi; Manjusha Thakar; Luigina De Leo; Nicola Di Toro; Tarcisio Not; Rithwik Ramachandran; Adam C Puche; Morley D Hollenberg; Alessio Fasano
Journal:  FASEB J       Date:  2010-09-17       Impact factor: 5.191

10.  Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2.

Authors:  Amit Tripathi; Karen M Lammers; Simeon Goldblum; Terez Shea-Donohue; Sarah Netzel-Arnett; Marguerite S Buzza; Toni M Antalis; Stefanie N Vogel; Aiping Zhao; Shiqi Yang; Marie-Claire Arrietta; Jon B Meddings; Alessio Fasano
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.